- Report
- July 2023
- 304 Pages
Global
From €4627EUR$4,799USD£3,957GBP
- Report
- March 2024
- 189 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- February 2024
- 412 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- February 2024
- 413 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- March 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- February 2024
- 175 Pages
Global
From €3856EUR$4,000USD£3,298GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- February 2024
- 175 Pages
Global
From €3856EUR$4,000USD£3,298GBP
- Report
- January 2024
- 276 Pages
Global
From €3856EUR$4,000USD£3,298GBP
- Report
- December 2023
- 200 Pages
Global
From €3856EUR$4,000USD£3,298GBP
- Report
- January 2024
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- January 2024
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- March 2024
- 180 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- November 2023
- 200 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- May 2024
- 246 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- February 2024
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- December 2023
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- April 2024
- 138 Pages
Global
From €3759EUR$3,899USD£3,215GBP
- Report
- March 2024
- 143 Pages
Global
From €3759EUR$3,899USD£3,215GBP
The Real World Evidence (RWE) market within the context of E-Healthcare is a rapidly growing sector. It is a form of evidence-based medicine that uses data from real-world sources such as patient records, claims data, and observational studies to inform healthcare decisions. RWE can be used to assess the safety and effectiveness of treatments, identify new indications for existing treatments, and inform healthcare policy. It can also be used to assess the cost-effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
RWE is increasingly being used by healthcare providers, payers, and pharmaceutical companies to inform their decisions. It is also being used by researchers to gain insights into the effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
Some companies in the RWE market include IBM Watson Health, Optum, Flatiron Health, and Evidation Health. Show Less Read more